Boehringer Ingelheim shares their initiatives on systematically operationalizing patient engagement within their drug

development lifecycle. Case examples will be shared that demonstrate:

• How they are building patient insights into their development and commercial programs

• How patient perspective differs based on region culture, and how they incorporate those considerations

Hilary Wilson, Director, Patient Engagement, Boehringer Ingelheim

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org